论文部分内容阅读
为观察百令胶囊对肾移植效果的影响，作者对２６３例术后在常规免疫抑制剂基础上加用百令胶囊的肾移植受者和６０例同等条件但未服用百令胶囊的受者进行了比较，结果发现加用百令胶囊者术后至少３个月内急性排斥反应发生机会明显减少；血白细胞降低以及环孢素Ａ肝、肾中毒发生率明显降低；患者抗病能力增强；术后６个月内上呼吸道感染发生率亦明显低于未服用百令胶囊者。由此可见百令胶囊是肾移植受者术后理想的辅助用药。
In order to observe the effects of Bailing capsule on renal transplantation, we performed 263 renal transplant recipients who received Bailing capsule and 60 recipients who did not take Bailing capsule after routine immunosuppressive therapy Compared with the results found that with Bailing capsule at least 3 months after surgery significantly reduced the chances of acute rejection; decreased blood leukocyte and cyclosporin A liver and kidney toxicity was significantly lower; patients with increased disease resistance; surgery The incidence of upper respiratory tract infection was also significantly lower in the first 6 months than those who had not taken Bailing capsule. This shows that Bailing capsule is an ideal adjuvant after renal transplant recipients.